Light Mode
$6.22 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.22, $0.28 below the day’s high of $6.50
+5.56 (+845.12%) / 6M
Momentum, market sentiment, and recent alerts
CMND reads not so good: price sits above one of the two key moving averages, the 12-month move is +667.7%.
No alerts for CMND in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.